OGEN
OGEN
AMEX · Biotechnology

Oragenics Inc

$0.73
+0.08 (+12.67%)
As of Feb 8, 2:34 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 484.7K 468.9K 455.7K
Net Income -93,000 -114,838 -98,507
EPS
Profit Margin -19.2% -24.5% -21.6%
Rev Growth +6.2% -0.5% +16.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.49M 1.53M 1.31M
Total Equity 1.95M 1.80M 1.90M
D/E Ratio 0.77 0.85 0.69
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -101,936 -104,145 -94,610
Free Cash Flow -84,967 -104,034 -103,597